How to Sustain Effective Concentration for a Longer Period with Long Acting Injectables

Liping Zhou, PhD, is currently a senior director at AstraZeneca Boston R&D center. She is heading the new modality formulation development and delivery science team, developing preclinical and clinical formulations and supporting AstraZeneca internal pipeline projects as well as external collaborations. Dr Zhou has 20 years of post-PhD technical and managerial experience in research and development functions in the biotechnology/pharmaceutical industry. She has diversified expertise especially in pre-formulation, formulation development and drug delivery technologies focusing on peptides, nucleic acids and small molecule drug candidates. She has been actively involved in preclinical and clinical programs, life-cycle management and due diligence projects in multiple therapeutical areas as well as efficiently and strategically managing external collaborations in the US, Europe and Asia. Dr Zhou’s previous employment includes but not limited to Novartis, Ipsen, and Ra Pharmaceuticals (now UCB). She co-authored more than 20 scientific publications in the leading biomedical journals and book chapters.Dr Zhou received her Ph.D. degree in Chemistry from University of Connecticut and her bachelor’s degree from Peking University.